BICILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Bicillin patents expire, and what generic alternatives are available?
Bicillin is a drug marketed by Wyeth Ayerst and King Pharms Llc and is included in five NDAs.
The generic ingredient in BICILLIN is penicillin g benzathine; penicillin g procaine. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.
Summary for BICILLIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BICILLIN |
DailyMed Link: | BICILLIN at DailyMed |
Recent Clinical Trials for BICILLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Tennessee | Phase 2 |
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |